Trials / Completed
CompletedNCT00216411
Effects on Quality of Life Following Dysport Treatment in Post-stroke Spasticity of the Arm
A Prospective Phase IV, Multicentre, Placebo-controlled Study to Demonstrate Changes in the Quality of Life Following DYSPORT Intramuscular Injection in the Treatment of Upper Limb Spasticity in Adult Post-Stroke Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to assess the effect on Quality of Life of two cycles of Dysport treatment on post-stroke spasticity of the upper limb. The effect of treatment on spasticity and function will also be measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Botulinum toxin type A | |
| DRUG | Placebo |
Timeline
- Start date
- 2004-11-01
- Primary completion
- 2006-07-20
- Completion
- 2006-07-20
- First posted
- 2005-09-22
- Last updated
- 2019-07-29
Locations
6 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT00216411. Inclusion in this directory is not an endorsement.